WebDegarelix injection is used to treat advanced prostate cancer (cancer that begins in the prostate [a male reproductive gland]). Degarelix injection is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. WebDec 13, 2012 · degarelix (Firmagon®) Formulation: 80 mg powder and solvent for solution for injection, 120 mg powder and solvent for solution for injection: Reference number: 755: Indication: Treatment of adult male patients with advanced hormone-dependent prostate cancer. Company: Ferring Pharmaceuticals (UK) BNF chapter: Malignant disease ...
Hormone therapy for prostate cancer - Mayo Clinic
WebFeb 1, 2024 · Firmagon at a starting dose of 240 mg (40 mg/mL) followed by monthly doses of 160 mg (40 mg/mL) subcutaneously. Firmagon is not approved for use with monthly doses of 160 mg (40 mg/mL) … WebDec 6, 2024 · Firmagon (degarelix) is a prescription drug that’s used to treat advanced prostate cancer in men. It comes as an injection. Learn about side effects, warnings, … fred levy accounting
FULL PRESCRIBING INFORMATION - HemOnc.org
WebFeb 2, 2024 · Join our team. Fagron is constantly growing in EMEA, North America and Latin America. With around 70 offices and compounding facilities, we have endless great … WebJan 13, 2024 · Posology. Adult. One depot of Zoladex LA injected subcutaneously into the anterior abdominal wall every 12 weeks. Renal impairment: no dosage adjustment is necessary for patients with renal impairment. Hepatic impairment: no dosage adjustment for patients with hepatic impairment. Paediatric population: Zoladex LA is not indicated for … WebDegarelix, sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer.. Testosterone is a male hormone that promotes … blinged up converse